Â鶹ӳ»­

In pursuit of its goals, the Department of Symptom Research employs a translational approach that ranges from bench to bedside and from bedside to bench. Our cross-cutting program integrates both preclinical and clinical research:

• Preclinical and translational research: The department's four Neuroimmunology Laboratories are conducting animal and in vitro studies to discover molecular and cellular mechanisms underlying the symptoms that develop in response to cancer and its treatment ¡ª for example, cognitive impairment, pain and fatigue. We are pursuing regenerative medicine and novel agents for treating neurotoxic symptoms.
• Clinical research: The department's Patient-Centered Analytics section engages in observational and interventional studies focused on educational, behavioral and medical interventions for cancer-related and treatment-related symptoms; creates methodologies for designing, validating, and deploying patient-reported outcomes assessment questionnaires; and develops innovative approaches that use machine learning and artificial intelligence to assess, analyze and predict patient outcomes.